Resmed (RSMDF) Asset Writedowns and Impairment (2009 - 2021)

Resmed (RSMDF) has reported Asset Writedowns and Impairment for 10 consecutive years, with -$5.1 million the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Asset Writedowns and Impairment changed N/A year-over-year to -$5.1 million; the trailing twelve-month figure through Jun 2021 stood at -$14.5 million (down 199.97% YoY), and the FY2023 full-year result was -$9.9 million, down 181.31% from the prior year.
• Asset Writedowns and Impairment eased to -$5.1 million in Q2 2021 per RSMDF's latest filing, from -$4.7 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $9.1 million in Q1 2020 and bottomed at -$8.5 million in Q3 2020.
• Historically, Asset Writedowns and Impairment has averaged $1.7 million across 5 years, with a median of $1.4 million in 2017.
• The sharpest annual moves came in 2018 and 2020: Asset Writedowns and Impairment jumped 483.25% in 2018, then tumbled 426.0% in 2020.
• Over 5 years, Asset Writedowns and Impairment stood at $1.3 million in 2017, then declined by 3.41% to $1.2 million in 2018, then soared by 125.88% to $2.8 million in 2019, then jumped by 31.25% to $3.7 million in 2020, then plunged by 237.11% to -$5.1 million in 2021.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$5.1 million, -$4.7 million, and $3.7 million for Q2 2021, Q1 2021, and Q4 2020 respectively.